Literature DB >> 10694198

Adverse effects of an active fragment of parathyroid hormone on rat hippocampal organotypic cultures.

T Hirasawa1, T Nakamura, A Mizushima, M Morita, I Ezawa, H Miyakawa, Y Kudo.   

Abstract

Adverse effects of an active fragment of parathyroid hormone (PTH(1 - 34)), a blood Ca(2+) level-regulating hormone, were examined using rat hippocampal slices in organotypic culture. Exposure of cultured slice preparations to 0.1 microM PTH(1 - 34) for 60 min resulted in a gradual increase in the intracellular Ca(2+) concentration ([Ca(2+)](i)); this effect was most obvious in the apical dendritic region of CA1 subfield. When PTH(1 - 34) at a lower concentration (1 nM) was added to the culture medium and its toxic effects examined using a propidium iodide intercalation method, significant toxicity was seen 3 days after exposure and increased with time. Cells in the CA1 region seemed more vulnerable to the hormone than cells in other regions. At 1 week of exposure, the toxic effects were dose-dependent over the range of 0.1 pM to 0.1 microM, the minimum effective dose being 10 pM. The adverse effects were not induced either by the inactive fragment, PTH(39 - 84), or by an active fragment of PTH-related peptide (PTHrP(1 - 34)), an intrinsic ligand of the brain PTH receptor. The PTH(1 - 34)-induced adverse effects were significantly inhibited by co-administration of 10 microM nifedipine, an L-type Ca(2+) channel blocker, but not by co-administration of blockers of the other types of Ca(2+) channel. The present study demonstrates that sustained high levels of PTH in the brain might cause degeneration of specific brain regions due to Ca(2+) overloading via activation of dihydropyridine-sensitive Ca(2+) channels, and suggests that PTH may be a risk factor for senile dementia. British Journal of Pharmacology (2000) 129, 21 - 28

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694198      PMCID: PMC1621111          DOI: 10.1038/sj.bjp.0702949

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Increase in single L-type calcium channels in hippocampal neurons during aging.

Authors:  O Thibault; P W Landfield
Journal:  Science       Date:  1996-05-17       Impact factor: 47.728

Review 2.  The calcium rationale in aging and Alzheimer's disease. Evidence from an animal model of normal aging.

Authors:  J F Disterhoft; J R Moyer; L T Thompson
Journal:  Ann N Y Acad Sci       Date:  1994-12-15       Impact factor: 5.691

Review 3.  Aging-related increase in hippocampal calcium channels.

Authors:  P W Landfield
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

Review 4.  Cytosolic and mitochondrial calcium in synaptosomes during aging.

Authors:  J Satrústegui; M Villalba; R Pereira; E Bogónez; A Martínez-Serrano
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

5.  Correlation between anti-ubiquitin immunoreactivity and region-specific neuronal death in N-methyl-D-aspartate-treated rat hippocampal organotypic cultures.

Authors:  M Okada; T Sakaguchi; K Kawasaki
Journal:  Neurosci Res       Date:  1995-07       Impact factor: 3.304

6.  Sprouting of CA3 pyramidal neurons to the dentate gyrus in rat hippocampal organotypic cultures.

Authors:  T Sakaguchi; M Okada; K Kawasaki
Journal:  Neurosci Res       Date:  1994-08       Impact factor: 3.304

7.  Histidine at position 5 is the specificity "switch" between two parathyroid hormone receptor subtypes.

Authors:  V Behar; C Nakamoto; Z Greenberg; A Bisello; L J Suva; M Rosenblatt; M Chorev
Journal:  Endocrinology       Date:  1996-10       Impact factor: 4.736

8.  Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat.

Authors:  T B Usdin; T I Bonner; G Harta; E Mezey
Journal:  Endocrinology       Date:  1996-10       Impact factor: 4.736

9.  Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor.

Authors:  T B Usdin; C Gruber; T I Bonner
Journal:  J Biol Chem       Date:  1995-06-30       Impact factor: 5.157

10.  Bone density, vitamin D nutrition, and parathyroid hormone levels in women with dementia.

Authors:  E Kipen; R D Helme; J D Wark; L Flicker
Journal:  J Am Geriatr Soc       Date:  1995-10       Impact factor: 5.562

View more
  6 in total

Review 1.  Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.

Authors:  Megan C Chapter; Caitlin M White; Angela DeRidder; Wayne Chadwick; Bronwen Martin; Stuart Maudsley
Journal:  Pharmacol Ther       Date:  2009-08-15       Impact factor: 12.310

2.  Aspartame and Soft Drink-Mediated Neurotoxicity in Rats: Implication of Oxidative Stress, Apoptotic Signaling Pathways, Electrolytes and Hormonal Levels.

Authors:  Mohamed A Lebda; Kadry M Sadek; Yasser S El-Sayed
Journal:  Metab Brain Dis       Date:  2017-06-28       Impact factor: 3.584

3.  Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromsø study.

Authors:  Rolf Jorde; Knut Waterloo; Farahnaz Saleh; Egil Haug; Johan Svartberg
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849

Review 4.  Class II G protein-coupled receptors and their ligands in neuronal function and protection.

Authors:  Bronwen Martin; Rakel Lopez de Maturana; Randall Brenneman; Tom Walent; Mark P Mattson; Stuart Maudsley
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 5.  Fall prevention and vitamin D in the elderly: an overview of the key role of the non-bone effects.

Authors:  Cedric Annweiler; Manuel Montero-Odasso; Anne M Schott; Gilles Berrut; Bruno Fantino; Olivier Beauchet
Journal:  J Neuroeng Rehabil       Date:  2010-10-11       Impact factor: 4.262

6.  The vitamin D, ionised calcium and parathyroid hormone axis of cerebral capillary function: therapeutic considerations for vascular-based neurodegenerative disorders.

Authors:  Virginie Lam; Ryusuke Takechi; Menuka Pallabage-Gamarallage; Corey Giles; John C L Mamo
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.